More about AstraZeneca Pharma India Limited

Technicals for AstraZeneca Pharma India Limited

The PSAR remains bullish, setting a strong support level that could underpin...

ASTRAZEN's current ratio being 1.872 suggests that it has more than enough...

The list of all important regulatory filings for AstraZeneca Pharma India Limited...

An analysis of JPMorgan Chase's $105 billion 2026 expense guidance, exploring its...

An investor-oriented article synthesising corporate leaders’ optimism for 2025 and the top...

An investor-focused analysis of major shifts in the financial services landscape as...

Last Updated:

2025-12-15 21:07

Published	Title	Summary
2025-07-11 12:21:52	Record Date	AstraZeneca Pharma India Limited has informed the Exchange that Record...
AstraZeneca Pharma India Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Jul-2025.
2025-01-20 16:56:30	Board Meeting Intimation	ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Board...
ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Board Meeting to be held on 11-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
2024-07-24 14:31:10	Board Meeting Intimation	ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Board...
ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .

DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.

If you have enjoyed reading, spread the word:

Lists of companies in NSE500 with the best and the worst fundamentals...

List of the latest important filings for NSE500....

Lists of companies in NSE500 with the best and the worst technicals...

An article analysing how new U.S. tariff policies are contributing to economic...

An article exploring Oracle’s latest quarterly results that reveal a significant AI...

An in-depth article analysing the Federal Reserve’s December 2025 rate cut and...